ProQR Therapeutics (PRQR) Enterprise Value Growth (3y) (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.16% |
| Dec 31, 2024 | 10.01% |
| Dec 31, 2023 | -11.86% |
| Sep 30, 2023 | 0.13% |
| Jun 30, 2023 | -4.42% |
| Mar 31, 2023 | 89.34% |
| Dec 31, 2022 | 7.53% |
| Sep 30, 2022 | -17.22% |
| Jun 30, 2022 | -12.10% |
| Mar 31, 2022 | -20.65% |
| Dec 31, 2021 | -22.05% |
| Sep 30, 2021 | -44.02% |
| Jun 30, 2021 | -17.57% |
| Mar 31, 2021 | 98.84% |
| Dec 31, 2020 | -17.31% |
| Sep 30, 2020 | 98.76% |
| Jun 30, 2020 | -12,273.30% |
| Mar 31, 2020 | -12,413.46% |
| Dec 31, 2019 | -24.69% |
| Sep 30, 2019 | -1,074.76% |
| Dec 31, 2018 | -5.04% |
| Sep 30, 2018 | 92.36% |
| Mar 31, 2018 | -7,616.79% |
| Dec 31, 2017 | 26.20% |
| Sep 30, 2017 | -11,012.48% |
| Mar 31, 2017 | 77.66% |
| Dec 31, 2016 | -124.89% |
| Sep 30, 2016 | 72.60% |